Ali Faraz — SEC Form 4 filings
SEC reporting owner CIK 1667937. 13 Form 4 filings on record with FilingPulse; latest filed 2026-09-11.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-02-16 to 2026-09-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 18 legs across 9 filings — 87,179 shares, $122,522 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: sale of 6,358 shares @ $5.86 ($37,258) in Tenaya Therapeutics, Inc., filed 2024-02-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Tenaya Therapeutics, Inc. (TNYA) | Chief Executive Officer, Director | 13 | — | 18 legs · 87,179 sh · $122,522 | 15 |
Form 4 filings — Ali Faraz
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-11 | 4 | Tenaya Therapeutics, Inc. (TNYA) | Grant/award (A): 122,000 @ $0 · Grant/award (A): 732,500 (derivative) @ $0 | EDGAR |
| 2026-08-17 | 4 | Tenaya Therapeutics, Inc. (TNYA) | Sale (S): 5,837 @ $0.71 · Sale (S): 3,969 @ $0.71 · Sale (S): 5,020 @ $0.71 · Sale (S): 7,406 @ $0.71 | EDGAR |
| 2026-05-19 | 4 | Tenaya Therapeutics, Inc. (TNYA) | Sale (S): 3,390 @ $0.79 | EDGAR |
| 2026-02-17 | 4 | Tenaya Therapeutics, Inc. (TNYA) | Sale (S): 5,851 @ $0.64 · Sale (S): 3,979 @ $0.64 · Sale (S): 5,032 @ $0.64 | EDGAR |
| 2026-02-05 | 4 | Tenaya Therapeutics, Inc. (TNYA) | Grant/award (A): 158,600 @ $0 · Grant/award (A): 952,250 (derivative) @ $0 | EDGAR |
| 2025-11-17 | 4 | Tenaya Therapeutics, Inc. (TNYA) | Sale (S): 3,126 @ $1.33 | EDGAR |
| 2025-08-18 | 4 | Tenaya Therapeutics, Inc. (TNYA) | Sale (S): 5,720 @ $1.25 · Sale (S): 3,893 @ $1.25 · Sale (S): 4,920 @ $1.25 | EDGAR |
| 2025-05-16 | 4 | Tenaya Therapeutics, Inc. (TNYA) | Sale (S): 3,189 @ $0.44 | EDGAR |
| 2025-03-10 | 4 | Tenaya Therapeutics, Inc. (TNYA) | Sale (S): 5,794 @ $0.54 · Sale (S): 3,947 @ $0.54 | EDGAR |
| 2025-02-07 | 4 | Tenaya Therapeutics, Inc. (TNYA) | Grant/award (A): 107,500 @ $0 · Grant/award (A): 34,424 @ $0 · Grant/award (A): 650,000 (derivative) @ $0 · Disposition to issuer (D): 353,271 (derivative) · Grant/award (A): 353,271 (derivative) · Disposition to issuer (D): 161,214 (derivative) · +3 more | EDGAR |
| 2024-08-16 | 4 | Tenaya Therapeutics, Inc. (TNYA) | Sale (S): 5,802 @ $2.89 · Sale (S): 3,946 @ $2.89 | EDGAR |
| 2024-02-27 | 4 | Tenaya Therapeutics, Inc. (TNYA) | Grant/award (A): 85,000 @ $0 · Grant/award (A): 505,000 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | Tenaya Therapeutics, Inc. (TNYA) | Sale (S): 6,358 @ $5.86 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1667937 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →